Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral labetalol versus oral alpha methyldopa for preeclampsia
PACTR202510836146767Not yet recruiting
- Sponsor
- Dr Fatima Rais Umar
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of labetalol and methyldopa in preeclampsia, sponsored by Dr Fatima Rais Umar. Primary endpoints: Change in mean systolic blood pressure at 48 hours and Change in mean diastolic blood pressure at 48 hours. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
labetalolmethyldopa
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202510836146767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510836146767.